Join the 'Deep Vein Thrombosis (DVT)' group to help and get support from people like you.

Deep Vein Thrombosis (DVT) Blog

Related terms: Blood clot in the legs, Deep venous thrombosis, Thromboembolism, DVT

Study Casts Doubt on Costly Treatment for Leg Clots

Posted 3 days ago by Drugs.com

TUESDAY, July 22, 2014 – Two treatments that break up blood clots deep in the veins of the legs appear no different in terms of death risk. However, one results in a greater risk of bleeding and average hospitalization bills that are three times the cost of the other treatment, a new study finds. The standard treatment for these clots – known as deep vein thrombosis (DVT) – is blood-thinning medications and compression stockings. The other, more expensive treatment delivers medication directly to the clot to dissolve it. This procedure, called catheter-directed thrombolysis, has increased in use in recent years despite inconclusive research as to its safety, the study authors said. "DVT is a very common disease that occurs in about one in 1,000 people per year," said lead researcher Dr. Riyaz Bashir, an associate professor of medicine at Temple University School of Medicine in ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

Pricey New Blood Thinner Eliquis Might Be Safer for Leg Clots

Posted 1 Jul 2013 by Drugs.com

MONDAY, July 1 – The new pill Eliquis prevents dangerous blood clots in the legs and lungs as well as standard therapy, though with less risk of serious bleeding, a new study shows. The research, published online July 1 in the New England Journal of Medicine, may point doctors toward a simpler, if more costly, way to prevent repeat blood clots in patients at risk for venous thromboembolism. Venous thromboembolism includes two related conditions: deep vein thrombosis (DVT) and pulmonary embolism. Together, these conditions hospitalize more than 500,000 adults each year in the United States, according to the government's National Hospital Discharge Survey. In DVT, a blood clot forms in the deep veins of the leg, causing swelling, redness, warmth and pain. If the blood clot breaks free, it can travel and lodge near the brain, heart or another vital organ, causing severe damage. If a clot ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Eliquis

Study Probes Use of Filter Device to Stop Deadly Blood Clots

Posted 18 Mar 2013 by Drugs.com

MONDAY, March 18 – The use of a special filter to prevent potentially deadly blood clots from traveling to patients' lungs varies widely among hospitals, a new study finds. A vena cava filter is placed in the inferior vena cava, the large vein in the abdomen that returns blood from the lower body to the heart. It is one of the treatments for people with blood clots that develop in the veins of the leg or pelvis (deep vein thrombosis). These blood clots can break free and travel to the lungs, where they can cause severe complications or death. A vena cava filter, which is designed to trap these clots before they reach the lungs, may be the only treatment option for patients who can't be given blood-thinning drugs. But one expert notes that the evidence around the effectiveness of these devices has never been clear. "Vena cava filters were once thought to be lifesaving devices in ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

New Blood Thinner Beats Older Drug for Vein Clots: Study

Posted 20 Feb 2013 by Drugs.com

WEDNESDAY, Feb. 20 – People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dabigatran) than with the older drug warfarin, researchers report. Long-term treatment of these blood clots is safer and more convenient with Pradaxa than warfarin, the new study found. Extended treatment with blood thinners after clots develop in the veins or the lungs should be considered more often than it is, said lead researcher Dr. Sam Schulman, a professor in the division of hematology and thromboembolism at McMaster University in Hamilton, Ontario, Canada. If a clot in the leg breaks loose and travels to the heart, brain or lungs, it can cause a heart attack, stroke or a pulmonary embolism – all of which can be fatal. People taking warfarin need periodic blood tests to be sure they aren't getting too much of the ... Read more

Related support groups: Coumadin, Warfarin, Pradaxa, Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Jantoven, Dabigatran

Migraine With Aura May Raise Risk of Heart Trouble

Posted 15 Jan 2013 by Drugs.com

TUESDAY, Jan. 15 – Women who suffer from migraines with visual effects called aura may face an increased risk for heart attacks, strokes and blood clots, new studies find. Only high blood pressure was a more powerful predictor of cardiovascular trouble, the researchers said. There are things women with this type of migraine can do to reduce that risk, they added: lower blood pressure and cholesterol levels, avoid smoking, eat healthfully and exercise. "Other studies have found that this form of migraine has been associated with the risk of stroke, and may be associated with any cardiovascular disease," said lead author Dr. Tobias Kurth, from the French National Institute of Health and Medical Research in Bordeaux and Brigham and Women's Hospital in Boston. "We find migraine with aura is a quite strong contributor to major cardiovascular disease. It is one of the top two risk factors." ... Read more

Related support groups: Migraine, Plan B, Sprintec, Mirena, Implanon, Provera, NuvaRing, Tri-Sprintec, Ischemic Stroke, Yasmin, Depo-Provera, Ortho Tri-Cyclen, Loestrin 24 Fe, Lutera, Heart Attack, TriNessa, Ortho Evra, Microgestin Fe 1/20, Mononessa, Ortho Tri-Cyclen Lo

New Blood Thinner May Help Prevent Leg Clots, Study Finds

Posted 9 Dec 2012 by Drugs.com

SATURDAY, Dec. 8 – The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds. People who suffer from venous thromboembolism are prone to develop blood clots in the veins in their legs (DVT). If a clot breaks loose, it can travel to the heart and cause a heart attack, or the brain and cause a stroke, or to the lungs and cause severe breathing difficulties, and even death. "This finding is great," said Dr. Maja Zaric, an interventional cardiologist at Lenox Hill Hospital in New York City. Currently, patients with recurrent venous thromboembolism take a drug called warfarin, which is effective but needs careful monitoring and is associated with a risk of major, and sometimes fatal, bleeding. This drug and others will likely replace warfarin over the next few years, Zaric said. ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

FDA Medwatch Alert: Heparin: Drug Safety Communication - Important change to heparin container labels to clearly state the total drug strength

Posted 7 Dec 2012 by Drugs.com

ISSUE: FDA is notifying health care professionals, caregivers, and patients about a change to the container and carton labels for heparin products. This label change will require manufacturers of Heparin Lock Flush Solution, USP and Heparin Sodium Injection, USP to clearly state the strength of the entire container of the medication followed by how much of the medication is in 1 milliliter (mL). These modifications will eliminate the need for health care professionals to calculate the total amount of heparin medication in a product containing more than 1 mL, thereby reducing the risk of miscalculations that may result in medication errors. BACKGROUND: Heparin is used to prevent blood clots from forming in people who have certain medical conditions or who are undergoing certain medical procedures that may increase the chance that clots will form, or to stop the growth of clots that have ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Heparin, Deep Vein Thrombosis, Hep-Pak, Heparin Sodium, Heparin Flush, Heparin Lock Flush, Hep-Lock, PosiFlush, Hep-Pak CVC

Xarelto's Approval Expanded

Posted 5 Nov 2012 by Drugs.com

MONDAY, Nov. 5 – Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism. DVT occurs when a blood clot forms in a vein deep in the body. If a clot breaks away and travels to an artery in the lungs, it becomes a potentially deadly condition called a pulmonary embolism. Xarelto was approved last year to treat clots stemming from knee or hip replacement and to lessen the risk of stroke in people with a form of abnormal heart rhythm called non-valvular atrial fibrillation. The drug's newest approvals were given based on clinical studies involving 9,478 people, the FDA said in a news release. As with other anti-clotting drugs, bleeding is the most common side effect. Xarelto is produced by Janssen Pharmaceuticals, based in Raritan, N.J. More information The FDA ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Deep Vein Thrombosis, Rivaroxaban

FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

Posted 2 Nov 2012 by Drugs.com

November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment. Blood clots occur when blood thickens and clumps together. DVT is a blood clot that forms in a vein deep in the body. Most deep vein blood clots occur in the lower leg or thigh. When a blood clot in a deep vein breaks off and travels to an artery in the lungs and blocks blood flow, it results in a potentially deadly condition called PE. Xarelto is already FDA-approved to reduce the risk of DVTs and PEs from occurring after knee or hip replacement surgery (July 2011), and to reduce the risk of stroke in people who have a type of abnormal heart rhythm called non-valvular atrial fibrillation (November 2011). The FDA reviewed ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Rivaroxaban, Deep Vein Thrombosis Prophylaxis after Abdominal Surgery, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis Prophylaxis after Orthopedic Surgery, Deep Vein Thrombosis Prophylaxis after General Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery

Infection Might Raise Blood Clot Risk for Older Adults: Study

Posted 5 Apr 2012 by Drugs.com

THURSDAY, April 5 – Infections, especially among older adults, may increase the risk of developing potentially dangerous blood clots, a new study suggests. The clots are called venous thromboembolisms, and include the deep vein thromboses (DVTs) that typically begin in the legs. However, DVTs can also travel to the lungs where they form potentially deadly pulmonary embolisms. DVTs have been linked to prolonged sitting, gaining the nickname "economy-class syndrome" after cases of passengers developing them on long-haul flights. But, the new study finds that if an older adult suffers an infection (for example, a urinary, skin or respiratory infection) after a stay in a hospital or nursing home, the risk of developing a venous thromboembolism can rise nearly sevenfold. In people who develop infections at home, the researchers found a threefold increased risk of a clot within 90 days. The ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Pulmonary Embolism, Deep Vein Thrombosis

Low Iron Levels May Increase Blood Clot Risk

Posted 15 Dec 2011 by Drugs.com

THURSDAY, Dec. 15 – Low levels of iron in the blood are associated with an increased risk of dangerous blood clots that form in a vein, according to the results of a new study that included patients with an inherited blood vessel disease. The findings suggest that treating iron deficiency may help prevent the condition known as deep vein thrombosis (DVT), according to the researchers at Imperial College London in England. DVT typically occurs in the legs and can cause pain and swelling, and can be fatal if a blood clot dislodges and travels into the blood vessels of the lungs. Major surgery, immobility and cancer are recognized risk factors for blood clots, but there is no clear cause in many cases. The new study included 609 patients with hereditary hemorrhagic telangiectasia (HHT), a genetic disease of the blood vessels that causes excessive bleeding from the nose and gut. Many HHT ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Iron Deficiency Anemia, Deep Vein Thrombosis

Cancer Patients at Risk for Serious Blood Clots: Study

Posted 30 Sep 2011 by Drugs.com

FRIDAY, Sept. 30 – Blood clots affect as many as one in five U.S. cancer patients and sharply increase the cost of their care, a new study has found. Researchers analyzed data from 30,552 cancer patients in the United States and found a large number developed a potentially deadly blood clot called a venous thromboembolism (VTE) within a year of undergoing chemotherapy for certain types of cancers. One year after treatment, VTE occurred in 21.5 percent of pancreatic cancer patients, 16.7 percent of stomach cancer patients, 14.8 percent of lung cancer patients, 11.9 percent of colorectal cancer patients, 11.4 percent of ovarian cancer patients and 9.9 percent of bladder cancer patients, the investigators found. It's not fully understood why VTEs can develop during cancer treatment, but contributing factors include chemotherapy side effects, blood-clotting agents released by tumors, and ... Read more

Related support groups: Cancer, Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

Central Catheters May Raise Risk of Blood Clots After Surgery

Posted 16 Aug 2011 by Drugs.com

TUESDAY, Aug. 16 – The risk of deep vein thrombosis – a sometimes deadly blood clot that can form in a deep vein after general surgery – is low when preventive measures such as anti-clotting drugs are used, researchers say. The investigators also found that most cases of deep vein thrombosis, or DVT, that occur after general surgery are associated with catheter use. In the new study, published in the Aug. 15 online edition of the journal Archives of Surgery, researchers reviewed the medical records of 2,189 patients across the United States who had general surgery in 2008 and 2009, including surgeries of the pancreas, esophagus, colon and rectum, intestines and stomach. DVT occurred in 35 (1.6 percent) of the patients, and 94.3 percent of those cases were detected because patients experienced DVT symptoms. Only 5.7 percent of the cases were found through routine screening. Sixty ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

Severe Blood Clots Should be Treated Aggressively: Heart Docs

Posted 21 Mar 2011 by Drugs.com

MONDAY, March 21 – The American Heart Association is urging doctors to treat the worst cases of potentially life-threatening blood clots that form in the legs' deep veins more aggressively. These clots can break loose and travel to the lungs, causing a pulmonary embolism, which can be fatal. Each year in the United States more than 250,000 people are hospitalized for deep vein thrombosis, whose symptoms include sudden swelling and unusual pain, tenderness and warmth in a leg. Until now, there has been little guidance on how best to treat the most serious cases of the emergency condition, according to the heart association. For patients, the new guidelines should make a difference in outcomes, said co-author Dr. M. Sean McMurtry, an assistant professor of medicine in the division of cardiology at the University of Alberta in Edmonton, Canada. "Ideally, it will lead to better care," he ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

New Blood Thinner May Help Fight Dangerous Leg Clots

Posted 6 Dec 2010 by Drugs.com

SATURDAY, Dec. 4 – A new anti-clotting pill, rivaroxaban (Xarelto), may be an effective, convenient and safer treatment for patients coping with deep-vein thrombosis (DVT), a pair of new studies indicate. According to the research, published online Dec. 4 in the New England Journal of Medicine, the drug could offer a new option for these potentially life-threatening clots, which most typically form in the lower leg or thigh. The findings are also slated for presentation Saturday at the annual meeting of the American Society of Hematology (ASH), in Orlando, Fla. "These study outcomes may possibly change the way that patients with DVT are treated," study author Dr. Harry R. Buller, a professor of medicine at the Academic Medical Center at the University of Amsterdam, said in an ASH news release. "This new treatment regimen of oral rivaroxaban can potentially make blood clot therapy ... Read more

Related support groups: Deep Vein Thrombosis (DVT), Deep Vein Thrombosis

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Deep Vein Thrombosis - Prophylaxis, Venous Thromboembolism

Related Drug Support Groups

Xarelto, Pradaxa, Lovenox, heparin, enoxaparin, Clexane, rivaroxaban, Arixtra, dabigatran, view more... fondaparinux, Normiflo, Heparin Sodium, tinzaparin, streptokinase, Innohep, Clexane Forte, Streptase, ardeparin, urokinase, Kinlytic, Kabikinase, Arixtra 10 mg/dose, Arixtra 7.5 mg/dose, Abbokinase Open-Cath, Abbokinase, Arixtra 5 mg/dose, Lovenox HP